Prognostic risk stratification value of MACC1 expression in patients with gastric cancer
- PMID: 38867026
- DOI: 10.1007/s12094-024-03550-0
Prognostic risk stratification value of MACC1 expression in patients with gastric cancer
Abstract
Background: The prognostic significance of metastasis-associated in colon cancer-1 (MACC1) has been explored in a variety of malignancies. However, its clinical relevance in patients with gastric cancer (GC) is limited, also remains controversial.
Method: In this study, we retrospectively evaluated the prognostic value of lesion MACC1 expression in 347 GC patients. Lesion MACC1 expression was analyzed with immunohistochemistry and grouped as MACC1low (n = 172) and MACC1high (n = 175) cases.
Results: Data revealed that the degree of MACC1 expression is not related to patient sex, age and disease stage (all p > 0.05). Survival analysis showed that only post-operation advanced pT (p = 0.018), pN (p < 0.001), pM (p = 0.001) and AJCC stages (p < 0.001) are significantly associated with shorter survival, while no obvious difference was observed between MACC1low and MACC1high cases (p = 0.158). However, we found that survival for female (p = 0.032), older (p = 0.028), and early disease stage (pT stage I + II, p = 0.033) patients with MACC1high are remarkably worse than those with MACC1low.
Conclusion: In summary, our findings revealed that, though MACC1 expression is not associated with the survival of the whole cohort, the prognostic risk stratification value of lesion MACC1 expression in subgroups of patients with gastric cancer should be noted.
Keywords: Gastric cancer; MACC1; Prognosis; Survival.
© 2024. The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO).
Conflict of interest statement
Declarations. Conflict of interest: All authors declare no conflict of interest. Ethical approval and consent to participate: This study protocol was reviewed and approved by Ethics Board of Taizhou Hospital of Zhejiang Province, China (K2D200824), and written informed consent from each participant was obtained prior to the surgery.
Similar articles
-
The expression of metastasis-associated in colon cancer-1 and KAI1 in gastric adenocarcinoma and their clinical significance.World J Surg Oncol. 2016 Oct 28;14(1):276. doi: 10.1186/s12957-016-1033-z. World J Surg Oncol. 2016. PMID: 27793161 Free PMC article.
-
Clinicopathological and prognostic significance of metastasis-associated in colon cancer-1 in gastric cancer: A meta-analysis.Int J Biol Markers. 2019 Mar;34(1):27-32. doi: 10.1177/1724600818813634. Epub 2019 Mar 10. Int J Biol Markers. 2019. PMID: 30854927
-
Circulating Metastasis Associated in Colon Cancer 1 transcripts in gastric cancer patient plasma as diagnostic and prognostic biomarker.World J Gastroenterol. 2015 Jan 7;21(1):333-41. doi: 10.3748/wjg.v21.i1.333. World J Gastroenterol. 2015. PMID: 25574109 Free PMC article.
-
The lncRNA MACC1-AS1 promotes gastric cancer cell metabolic plasticity via AMPK/Lin28 mediated mRNA stability of MACC1.Mol Cancer. 2018 Mar 6;17(1):69. doi: 10.1186/s12943-018-0820-2. Mol Cancer. 2018. PMID: 29510730 Free PMC article.
-
Metastasis-associated in colon cancer-1 in gastric cancer: Beyond metastasis.World J Gastroenterol. 2016 Aug 7;22(29):6629-37. doi: 10.3748/wjg.v22.i29.6629. World J Gastroenterol. 2016. PMID: 27547006 Free PMC article. Review.
References
-
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660 . - DOI - PubMed
-
- Cao W, Chen HD, Yu YW, Li N, Chen WQ. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin Med J (Engl). 2021;134(7):783–91. https://doi.org/10.1097/CM9.0000000000001474 . - DOI - PubMed
-
- Stein U, Walther W, Arlt F, Schwabe H, Smith J, Fichtner I, et al. MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nat Med. 2009;15(1):59–67. https://doi.org/10.1038/nm.1889 . - DOI - PubMed
-
- Radhakrishnan H, Walther W, Zincke F, Kobelt D, Imbastari F, Erdem M, et al. MACC1-the first decade of a key metastasis molecule from gene discovery to clinical translation. Cancer Metastasis Rev. 2018;37(4):805–20. https://doi.org/10.1007/s10555-018-9771-8 . - DOI - PubMed
-
- Torke S, Walther W, Stein U. Immune Response and Metastasis-Links between the metastasis driver MACC1 and cancer immune escape strategies. Cancers (Basel). 2024;16(7):1330. https://doi.org/10.3390/cancers16071330 . - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous